IMP3, a Promising Prognostic Marker in Clear Cell Renal Cell Carcinoma

BACKGROUND: Insulin-like growth factor II mRNA-binding protein 3 (IMP3) has been reported as a prognostic biomarker in various cancers. To validate IMP3 as a prognostic biomarker in renal cell carcinoma (RCC), we investigated the expression of IMP3, p53, and Ki-67, and their associations with clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Ji Young, Choe, Misun, Kang, Yuna, Lee, Sang Sook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Pathologists and The Korean Society for Cytopathology 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026801/
https://www.ncbi.nlm.nih.gov/pubmed/24868223
http://dx.doi.org/10.4132/KoreanJPathol.2014.48.2.108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026801/
https://www.ncbi.nlm.nih.gov/pubmed/24868223
http://dx.doi.org/10.4132/KoreanJPathol.2014.48.2.108

Ejemplares similares